Delivery Order SPE2DR25D1053-SPE2DR26FV083
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,719.49 to AmerisourceBergen Drug Corp for the supply of Miebo 100% eye drop solution in 3ml quantities. This non-set-aside contract was competitively awarded on April 23, 2025, with an ultimate completion date of April 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The firm fixed price delivery order represents a component of AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $19,377.99 to AmerisourceBergen Drug Corp for Miebo 100% eye drop (3ml) on December 17, 2025, with an ultimate completion date of December 18, 2025. The contract employs firm fixed price terms and carries no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,607.96 delivery order to AmerisourceBergen Drug Corp for Miebo 100% eye drops (3 milliliter units) on December 11, 2025, with a completion date of December 12, 2025. This is a non-set-aside, competitively awarded contract utilizing firm fixed pricing. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,658.80 to AmerisourceBergen Drug Corp for Miebo 100% eye drop solution (3mL) on December 29, 2025, with completion expected by December 30, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,655.19 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop medication in 3ML units. This firm fixed-price delivery order, issued on November 18, 2025, with an ultimate completion date of November 19, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,228.97 to AmerisourceBergen Drug Corp for the supply of Miebo 100% eye drops (3mL) on September 23, 2025, with completion scheduled for September 24, 2025. This competitively awarded, firm fixed-price delivery order was placed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,024.73 to AmerisourceBergen Drug Corp for Miebo 100% eye drop solution (3ml) on December 22, 2025, with an ultimate completion date of December 23, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA....
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Miebo 100% eye drop in 3ml quantities, with a ceiling value of $36,483.26. This firm fixed-price delivery order, which is not set-aside for any special contracting category, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and running through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,529.96 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3 mL) on December 16, 2025, with completion scheduled for December 17, 2025. This non-competitive delivery order was issued under a firm fixed price arrangement and represents a small-value pharmaceutical procurement supporting federal medical supply requirements. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Miebo 100% eye drop solution (3mL units) under a firm fixed-price contract valued at $16,900.25, with a completion deadline of December 5, 2025. This non-set-aside delivery order represents a competitive procurement of specialized pharmaceutical products supporting federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV083Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,898.94 to AmerisourceBergen Drug Corp for the supply of Miebo 100% eye drop solution in 3ml quantities. The contract, issued on December 30, 2025, carries a completion date of December 31, 2025, and utilizes firm fixed-price pricing with no small business set-aside. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement designated SPE2DX and extending through December 2026. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical supplier to federal medical procurement programs, particularly for military and veteran healthcare systems. The company maintains a comprehensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a non-set-aside, competitively awarded contract, this delivery order reflects AmerisourceBergen's established capability to meet federal procurement requirements through open competition. The DLA Medical Supply Chain leverages such contracts to ensure reliable pharmaceutical supply for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.9k | 12/29/25 |